COMPANY
Clinical Phase 1
Keywords: small molecule oncology chronic myelomonocytic leukemia Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia-1 Chronic Myelomonocytic Leukemia-2 Refractory Chronic Myelomonocytic Leukemia CMML Acute Myeloid Leukemia Post Cytotoxic Therapy Refractory Acute Myeloid Leukemia (AML) Acute Monocytic Leukemia STX-0712
Location: Boston, MA · source · Oct 14, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start 1: A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) source ↗
Upcoming milestones
- Dec 31, 2026 (ESTIMATED) · 1 · A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) · NCT06950034
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT06950034 | A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) | 1 | Recruiting | Mar 13, 2025 | Dec 31, 2026 (estimated) |
